Skip to main content

Emily Olsen

By Emily Olsen | 04:27 pm | March 16, 2022
Also: Papa moves into the employer market, and Lark Health is working on a heart health platform.
HIMSS22
By Emily Olsen | 11:38 am | March 16, 2022
During a session at HIMSS22, panelists discussed how provider-based venture capital firms, accelerators and incubators can help digital health startups understand and collaborate with the larger healthcare industry.
HIMSS22
By Emily Olsen | 08:37 pm | March 15, 2022
During a discussion at HIMSS22, venture capital panelists discussed the big investment trends, funding in 2022 and the role of big tech.
By Emily Olsen | 03:24 pm | March 15, 2022
Also: OpenLoop raises $8 million for its virtual care staffing and support services, and metaMe Health scoops up $2.2 million to prepare for the market launch of its prescription digital therapeutic.
HIMSS22
By Emily Olsen | 10:56 am | March 15, 2022
During a session at HIMSS22, panelists discuss how healthcare organizations can build and maintain unbiased AI.
By Emily Olsen | 09:48 am | March 15, 2022
Gastrointestinal-care startup Oshi Health raised $23 million in Series A financing last year.
By Emily Olsen | 05:16 pm | March 14, 2022
The partnership with Zuellig Pharma includes Ensemble, Happify's therapeutic for treating major depressive disorder and generalized anxiety disorder, and a prescription digital therapeutic for chronic insomnia.
By Emily Olsen | 01:59 pm | March 11, 2022
Also: Avant-garde Health raises $12 million for its surgical care analytics platform, Canadian care navigation startup Clinia scoops up $5 million and mental health clinician staffing company Legion Health scores $2 million.
By Emily Olsen | 11:42 am | March 11, 2022
During a panel discussion at ViVE, panelists discuss the importance of set-up support and provider input when using technology for managing chronic conditions in the home.
By Emily Olsen | 02:12 pm | March 10, 2022
The five-year deal will utilize PathAI's algorithms for translational research and clinical diagnostics.